Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.

[1]  S. Graham,et al.  Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. , 2019, Ophthalmology.

[2]  S. Graham,et al.  Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease , 2019, Brain : a journal of neurology.

[3]  M. Gillies,et al.  Characterization of canonical Wnt signalling changes after induced disruption of Müller cell in murine retina , 2018, Experimental eye research.

[4]  U. Grünert,et al.  Disruption of De Novo Serine Synthesis in Müller Cells Induced Mitochondrial Dysfunction and Aggravated Oxidative Damage , 2018, Molecular Neurobiology.

[5]  E. C. Graham,et al.  Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[6]  J. Seze,et al.  MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease? , 2017, Brain : a journal of neurology.

[7]  Min Zhao,et al.  Mechanisms of macular edema: Beyond the surface , 2017, Progress in Retinal and Eye Research.

[8]  E. C. Graham,et al.  Progression of retinal ganglion cell loss in multiple sclerosis is associated with new lesions in the optic radiations , 2017, European journal of neurology.

[9]  T. Yamamura,et al.  Foveal thinning in neuromyelitis optica , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[10]  F. Paul,et al.  Microstructural visual system changes in AQP4-antibody–seropositive NMOSD , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[11]  T. Kanda,et al.  Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[12]  A. Verkman,et al.  Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G , 2016, Journal of Neuroinflammation.

[13]  E. Kremmer,et al.  Expression and Distribution Pattern of Aquaporin 4, 5 and 11 in Retinas of 15 Different Species , 2016, International journal of molecular sciences.

[14]  Pablo Villoslada,et al.  The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.

[15]  H. Kim,et al.  Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder , 2016, Journal of Neurology.

[16]  V. Fung,et al.  Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis , 2016, Multiple sclerosis.

[17]  E. C. Graham,et al.  Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study. , 2016, Investigative ophthalmology & visual science.

[18]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[19]  Jacqueline Palace,et al.  Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography , 2015, Multiple sclerosis.

[20]  G. Plant,et al.  Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria , 2015, Multiple sclerosis.

[21]  S. Zamvil,et al.  Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[22]  E. Nagelhus,et al.  Physiological roles of aquaporin-4 in brain. , 2013, Physiological reviews.

[23]  M. Papadopoulos,et al.  Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.

[24]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.

[25]  Jacqueline Palace,et al.  Serologic diagnosis of NMO , 2012, Neurology.

[26]  M. Romero,et al.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes , 2011, Proceedings of the National Academy of Sciences.

[27]  Seang-Mei Saw,et al.  Application of advanced statistics in ophthalmology. , 2011, Investigative ophthalmology & visual science.

[28]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[29]  M. Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2008 update) , 2009, Documenta Ophthalmologica.

[30]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[31]  Geoffrey T Manley,et al.  Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin‐4 water channels , 2006, Glia.

[32]  E. Nagelhus,et al.  Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1 , 2004, Neuroscience.

[33]  A. Verkman,et al.  Mildly abnormal retinal function in transgenic mice without Müller cell aquaporin-4 water channels. , 2002, Investigative ophthalmology & visual science.

[34]  J. Gass,et al.  Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. , 1999, Archives of ophthalmology.

[35]  J. Robson,et al.  Dissecting the dark-adapted electroretinogram , 1998, Documenta Ophthalmologica.

[36]  L. Frishman.  Chapter 6 – Electrogenesis of the Electroretinogram , 2006 .

[37]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .